CDKN2A and melanoma: CDKN2A mutation carriers tend to have multiple primary melanomas, early onset melanoma and an increased risk of developing pancreatic cancer [5] and have also been shown to have an increased risk of tobacco associated cancers in respiratory and digestive tissues [6, 7].